1. Home
  2. GNSS vs TIL Comparison

GNSS vs TIL Comparison

Compare GNSS & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genasys Inc.

GNSS

Genasys Inc.

HOLD

Current Price

$1.89

Market Cap

84.1M

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$8.26

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNSS
TIL
Founded
1992
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.1M
74.7M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
GNSS
TIL
Price
$1.89
$8.26
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$4.75
$125.00
AVG Volume (30 Days)
96.8K
22.1K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
44.44
6.06
EPS
N/A
N/A
Revenue
$26,306,790.00
N/A
Revenue This Year
$80.08
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
29.50
N/A
52 Week Low
$1.40
$5.67
52 Week High
$2.70
$42.75

Technical Indicators

Market Signals
Indicator
GNSS
TIL
Relative Strength Index (RSI) 52.95 44.47
Support Level $1.87 $7.88
Resistance Level $2.05 $9.03
Average True Range (ATR) 0.08 0.53
MACD 0.00 -0.04
Stochastic Oscillator 41.68 37.68

Price Performance

Historical Comparison
GNSS
TIL

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: